Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
Finn Sellebjerg, Morten Blinkenberg, Per Soelberg Sørensen
Topics & Concepts
OcrelizumabMultiple sclerosisOfatumumabCD20RituximabMonoclonal antibodyMedicineImmunologyNatalizumabAntibodyDemyelinating diseaseMonoclonalPathogenesisB cellEpitopeMultiple Sclerosis Research StudiesT-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies Research